HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FATTY ACID BIOSYNTHESIS FOR BACTERIAL INFECTIONS

The present invention relates to novel heterocyclic compounds which specifically inhibit bacterial Fab I and can be used for the treatment of Staphylococcal infections..

Medienart:

Patent

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Europäisches Patentamt - (2021) vom: 11. Mai Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Beteiligte Personen:

RANGARAJAN RADHA [VerfasserIn]
KUMAR RAJINDER [VerfasserIn]
PRABHAKAR B V [VerfasserIn]
CHANDRASEKHAR P [VerfasserIn]
MALLIKARJUNA P [VerfasserIn]
BANERJEE ANKITA [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2021-05-11, Last update posted on www.tib.eu: 2023-10-09, Last updated: 2023-10-13

Patentnummer:

CA2849057

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA015316564